| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.0056 | 1 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |